|
Delayed
Bombay S.E.
06:32:02 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 165.00 INR | -0.30% |
|
-0.99% | -37.34% |
| 09-22 | Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading | MT |
| 09-22 | Oracle, Wipro Collaborate on Pharmacovigilance Services for Life Sciences | MT |
Company Valuation: Wipro Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,236,060 | 2,000,894 | 2,505,134 | 2,741,626 | 1,964,851 | 1,637,165 | - | - |
| Change | - | -38.17% | 25.2% | 9.44% | -28.33% | -16.68% | - | - |
| Enterprise Value (EV) 1 | 3,042,265 | 1,749,875 | 2,238,476 | 2,369,995 | 1,589,490 | 1,350,010 | 1,309,638 | 1,253,310 |
| Change | - | -42.48% | 27.92% | 5.88% | -32.93% | -15.07% | -2.99% | -4.3% |
| P/E | 26.6x | 17.7x | 23.1x | 20.9x | 14.9x | 12.4x | 11.9x | 11.4x |
| PBR | 4.93x | 2.56x | 3.38x | 3.33x | 2.23x | 2.02x | 1.91x | 1.81x |
| PEG | - | -2.45x | 34.12x | 1x | 46.64x | 1.94x | 2.66x | 2.89x |
| Capitalization / Revenue | 4.09x | 2.21x | 2.79x | 3.08x | 2.12x | 1.66x | 1.61x | 1.57x |
| EV / Revenue | 3.85x | 1.93x | 2.49x | 2.66x | 1.72x | 1.37x | 1.29x | 1.2x |
| EV / EBITDA | 18.5x | 10.4x | 13.2x | 13.1x | 8.9x | 7.02x | 6.51x | 6.09x |
| EV / EBIT | 22.4x | 12.9x | 16.5x | 15.7x | 10.4x | 8.38x | 7.75x | 7.22x |
| EV / FCF | 33.6x | 15.1x | 13.5x | 15.3x | 11.9x | 9.95x | 8.99x | 8.39x |
| FCF Yield | 2.98% | 6.62% | 7.4% | 6.53% | 8.41% | 10.1% | 11.1% | 11.9% |
| Dividend per Share 2 | 3 | 0.5 | 0.5 | 6 | 11 | 9.047 | 11.15 | 11.19 |
| Rate of return | 1.01% | 0.27% | 0.21% | 2.29% | 5.87% | 5.47% | 6.74% | 6.76% |
| EPS 2 | 11.14 | 10.34 | 10.41 | 12.52 | 12.56 | 13.36 | 13.96 | 14.51 |
| Distribution rate | 26.9% | 4.84% | 4.8% | 47.9% | 87.6% | 67.7% | 79.8% | 77.1% |
| Net sales 1 | 790,934 | 904,876 | 897,603 | 890,884 | 926,240 | 987,400 | 1,017,416 | 1,045,069 |
| EBITDA 1 | 164,523 | 168,479 | 169,830 | 180,818 | 178,626 | 192,393 | 201,287 | 205,743 |
| EBIT 1 | 135,931 | 135,134 | 135,759 | 151,239 | 152,154 | 161,150 | 168,948 | 173,525 |
| Net income 1 | 122,191 | 113,500 | 110,452 | 131,354 | 131,974 | 134,908 | 140,693 | 146,313 |
| Net Debt 1 | -193,795 | -251,019 | -266,658 | -371,631 | -375,361 | -287,154 | -327,527 | -383,854 |
| Reference price 2 | 296.00 | 182.65 | 240.02 | 262.10 | 187.55 | 165.50 | 165.50 | 165.50 |
| Nbr of stocks (in thousands) | 10,932,636 | 10,954,798 | 10,436,972 | 10,460,231 | 10,476,409 | 9,892,233 | - | - |
| Announcement Date | 29/04/22 | 27/04/23 | 19/04/24 | 16/04/25 | 16/04/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.38x | 1.37x | 7.02x | 5.47% | 17.13B | |
| 22.77x | 3.72x | 12.99x | 2.92% | 218B | |
| -133.08x | 18.57x | 102.94x | -.--% | 119B | |
| 13.62x | 1.5x | 7.9x | 3.51% | 112B | |
| 13.78x | 2.51x | 9.46x | 5.96% | 79.67B | |
| 19.36x | 5.14x | 12.63x | 2.93% | 56.86B | |
| 13.62x | 1.97x | 8.34x | 5.72% | 43.61B | |
| 22.36x | 1.83x | 11.42x | 1.31% | 43.86B | |
| 21.06x | 1.6x | 10.17x | 0.89% | 40.55B | |
| 17.31x | 2.21x | 10.58x | 4.98% | 35.96B | |
| Average | 2.32x | 4.04x | 19.35x | 3.37% | 76.67B | |
| Weighted average by Cap. | -5.00x | 5.23x | 25.02x | 2.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WIPRO Stock
- Valuation Wipro Limited
Select your edition
All financial news and data tailored to specific country editions
